Patients with insulin-dependent diabetes are at greater risk for perioperative adverse outcomes following total hip arthroplasty.

Autor:	Webb ML; Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA., Justen MA; Department of Orthopaedics and Rehbailitation, Yale School of Medicine, New Haven, CT, USA., Kerbel YE; Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA., Scanlon CM; Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA., Nelson CL; Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA, USA., Grauer JN; Department of Orthopaedics and Rehbailitation, Yale School of Medicine, New Haven, CT, USA.
Jazyk:	angličtina
Zdroj:	Hip international : the journal of clinical and experimental research on hip pathology and therapy [Hip Int] 2022 Nov; Vol. 32 (6), pp. 730-736. Date of Electronic Publication: 2021 Feb 10.
DOI:	10.1177/1120700020988834
Abstrakt:	Background: The prevalence of diabetes mellitus (DM) continues to increase among patients undergoing total hip arthroplasty (THA). It is unclear how insulin use is correlated with risk for adverse outcomes. Methods: A cohort of 146,526 patients undergoing primary THA were identified in the 2005-2017 National Surgical Quality Improvement Program database. Patients were classified as insulin-dependent diabetic (IDDM), non-insulin-dependent diabetic (NIDDM), or not diabetic. Multivariate analyses were used. Results: Compared to patients without diabetes, patients with NIDDM were at increased risk for 4 of 17 perioperative adverse outcomes studied. Patients with IDDM were at increased risk for those 4 and 8 additional adverse outcomes (12 of the 17 studied). Conclusion: These findings have important implications for preoperative risk stratification and quality improvement initiatives.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu